News Conference News TCT 2017 ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure Michael O'Riordan November 02, 2017
News Conference News TCT 2017 No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS Michael O'Riordan October 30, 2017
News Daily News CTA Reduces MI Compared With Functional Stress Testing, but at a Cost Michael O'Riordan October 05, 2017
News Conference News ESC 2017 CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events Michael O'Riordan August 27, 2017
News Daily News Cardiac Testing in Chest Pain Patients Without Ischemia Does Not Reduce Acute MI Admissions Michael O'Riordan June 28, 2017
News Industry News New Data from PLATINUM Diversity Study Presented at SCAI 2017 Provide Important Insights Beyond Traditional Clinically-Reported Endpoints May 12, 2017
News Conference News ACC 2017 FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo Michael O'Riordan March 17, 2017
News Conference News ACC 2017 Erectile Dysfunction Meds Linked to Fewer Death and HF Hospitalizations After MI L.A. McKeown March 09, 2017
News Daily News DESolve Bioresorbable Stent Compares Well With Absorb, but Longer Follow-up Needed Michael O'Riordan February 16, 2017
News Features Be It Resolved: Lifestyle Changes for Patients Needing Cardiac Rehab May Be a Life or Death Matter Michael O'Riordan January 10, 2017